Urinary Oxygenation as a Surrogate Measure of Medullary Oxygenation during Angiotensin II Therapy in Septic Acute Kidney Injury

Critical Care Medicine

Volumn 46, Issue 1, 2018, Pages e41-e48

  Lankadeva, Yugeesh R ^a   Kosaka, Junko ^a   Evans, Roger G ^b   Bellomo, Rinaldo ^c,d   May, Clive N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c AUSTIN HEALTH   (Australia)

^d Australian New Zealand Intensive Care Research Centre   (Australia)

Author keywords

acute kidney injury; angiotensin II; biomarkers; hypoxia; sepsis

Indexed keywords

ANGIOTENSIN II; BIOLOGICAL MARKER; CREATININE; INTERLEUKIN 10; INTERLEUKIN 6; LACTIC ACID; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM; SODIUM CHLORIDE; CYTOKINE; OXYGEN;

ACUTE KIDNEY FAILURE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONDUCTANCE; CONTROLLED STUDY; CORE TEMPERATURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; HEART OUTPUT; HEART RATE; HYPOTENSION; HYPOXIA; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY MEDULLA; KIDNEY PERFUSION; LACTATE BLOOD LEVEL; MEAN ARTERIAL PRESSURE; MERINO SHEEP; MICTURITION; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RENAL VASCULAR CONDUCTANCE; SEPSIS; SEPTIC SHOCK; SODIUM EXCRETION; VALIDITY; VASOCONSTRICTION; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; FEMALE; HEMODYNAMICS; KIDNEY FUNCTION TEST; SHEEP; URINE; VASCULARIZATION;

ACUTE KIDNEY INJURY; ANGIOTENSIN II; ANIMALS; BIOMARKERS; BLOOD PRESSURE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMICS; KIDNEY FUNCTION TESTS; KIDNEY MEDULLA; OXYGEN; SEPSIS; SHEEP;

EID: 85038229255     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002797     Document Type: Article

References (40)

1. Alobaidi R Basu RK Goldstein SL. Sepsis-associated acute kidney injury. Semin Nephrol 2015; 35: 2 11
2. Bagshaw SM Lapinsky S Dial S; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group: Acute kidney injury in septic shock: Clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009; 35: 871 881
3. Heyman SN Evans RG Rosen S. Cellular adaptive changes in AKI: mitigating renal hypoxic injury. Nephrol Dial Transplant 2012; 27: 1721 1728
4. Evans RG Ince C Joles JA. Haemodynamic influences on kidney oxygenation: Clinical implications of integrative physiology. Clin Exp Pharmacol Physiol 2013; 40: 106 122
5. Post EH Kellum JA Bellomo R. Renal perfusion in sepsis: From macro-to microcirculation. Kidney Int 2017; 91: 45 60
6. Lankadeva YR Kosaka J Evans RG. Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury. Kidney Int 2016; 90: 100 108
7. Calzavacca P Evans RG Bailey M. Cortical and medullary tissue perfusion and oxygenation in experimental septic acute kidney injury. Crit Care Med 2015; 43: e431 e439
8. Rhodes A Evans LE Alhazzani W. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43: 304 377
9. Morelli A Ertmer C Westphal M. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial. JAMA 2013; 310: 1683 1691
10. Dünser MW Hasibeder WR. Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med 2009; 24: 293 316
11. Andreis DT Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med 2016; 42: 1387 1397
12. Corrêa TD Takala J Jakob SM. Angiotensin II in septic shock. Crit Care 2015; 19: 98
13. Chawla LS Busse L Brasha-Mitchell E. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): A pilot study. Crit Care 2014; 18: 534
14. Yunge M Petros A. Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 2000; 82: 388 389
15. Antonucci E Gleeson PJ Annoni F. Angiotensin II in refractory septic shock. Shock 2017; 47: 560 566
16. Wray GM Coakley JH. Severe septic shock unresponsive to noradrenaline. Lancet 1995; 346: 1604
17. Chawla L Russell J Bagshaw S. Angiotensin II for the treatment of high output shock-3 (ATHOS-3): Protocol for a phase III, double-blind, randomised controlled trial. Crit Care Resusc 2017; 19: 43 49
18. Wan L Langenberg C Bellomo R. Angiotensin II in experimental hyperdynamic sepsis. Crit Care 2009; 13: R190
19. Di Giantomasso D May CN Bellomo R. Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis. Intensive Care Med 2003; 29: 1774 1781
20. Kanoore Edul VS Dubin A Ince C. The microcirculation as a therapeutic target in the treatment of sepsis and shock. Semin Respir Crit Care Med 2011; 32: 558 568
21. Coca SG Parikh CR. Urinary biomarkers for acute kidney injury: Perspectives on translation. Clin J Am Soc Nephrol 2008; 3: 481 490
22. Lehner GF Forni LG Joannidis M. Oliguria and biomarkers of acute kidney injury: Star struck lovers or strangers in the night? Nephron 2016; 134: 183 190
23. Mårtensson J Bellomo R. The rise and fall of NGAL in acute kidney injury. Blood Purif 2014; 37: 304 310
24. Sgouralis I Kett MM Ow CP. Bladder urine oxygen tension for assessing renal medullary oxygenation in rabbits: Experimental and modeling studies. Am J Physiol Regul Integr Comp Physiol 2016; 311: R532 R544
25. Langenberg C Wan L Egi M. Renal blood flow in experimental septic acute renal failure. Kidney Int 2006; 69: 1996 2002
26. Calzavacca P Evans RG Bailey M. Long-term measurement of renal cortical and medullary tissue oxygenation and perfusion in unanesthetized sheep. Am J Physiol Regul Integr Comp Physiol 2015; 308: R832 R839
27. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994; 28: 303 311
28. Ludbrook J. A primer for biomedical scientists on how to execute model II linear regression analysis. Clin Exp Pharmacol Physiol 2012; 39: 329 335
29. Alves-Filho JC Sônego F Souto FO. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 2010; 16: 708 712
30. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005; 9 (Suppl 4): S13 S19
31. Souza AC Yuen PS Star RA. Microparticles: Markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI. Kidney Int 2015; 87: 1100 1108
32. Chelazzi C Villa G Mancinelli P. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care 2015; 19: 26
33. Blum MS Toninelli E Anderson JM. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am J Physiol 1997; 273: H286 H294
34. Matejovic M Ince C Chawla LS; ADQI XIII Work Group: Renal hemodynamics in AKI: In search of new treatment targets. J Am Soc Nephrol 2016; 27: 49 58
35. Khanna A English SW Wang XS; ATHOS-3 Investigators: Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 2017; 377: 419 430
36. Corrêa TD Jeger V Pereira AJ. Angiotensin II in septic shock: Effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis. Crit Care Med 2014; 42: e550 e559
37. May CN Ishikawa K Wan L. Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion. Intensive Care Med 2012; 38: 886 893
38. Busse LW Wang XS Chalikonda DM. Clinical experience with IV Angiotensin II administration: A Systematic Review of Safety. Crit Care Med 2017; 45: 1285 1294
39. Eppel GA Bergstrom G Anderson WP. Autoregulation of renal medullary blood flow in rabbits. Am J Physiol Regul Integr Comp Physiol 2003; 284: R233 R244
40. Calzavacca P Evans RG Bailey M. Variable responses of regional renal oxygenation and perfusion to vasoactive agents in awake sheep. Am J Physiol Regul Integr Comp Physiol 2015; 309: R1226 R1233